Short description
HDL Therapeutics is a medical device company that develops cardiovascular therapeutic device designed to fight heart disease.
Description
HDL Therapeutics have developed the first therapy of its kind to rapidly reverse coronary atherosclerosis in patients with Homozygous Familial Hypercholesterolemia (HoFH).
Last funding
Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Vero Beach, Florida, United States, North America
Founded on
January 1, 2009
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$34056 - 789030
Sign in for full access
Founders
Bryan Brewer, Michael Matin